AI assistant
HEALIUS LIMITED — Director's Dealing 2022
Sep 1, 2022
65058_rns_2022-09-01_e19b6127-78b0-447d-b18a-e5e78f0d8640.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| Name | of | entity | HEALIUS LIMITED |
|---|---|---|---|
| ABN | 24 064 530 516 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Gordon Richard Davis |
|---|---|
| Date of last notice | 24 February2022 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
==> picture [434 x 319] intentionally omitted <==
----- Start of picture text ----- Direct or indirect interest DirectNature of indirect interest(including registered holder) N/ANote: Provide details of the circumstances givingrise to the relevant interest.Date of change 02 September 20228,032 NED Share Rights Gordon Davis8,032 Ordinary Shares* Gordon DavisNo. of securities held prior tochangeGR & G Davis55,759 Ordinary SharesSuperannuation Fund* Shares are subject to a holding lock as “Restricted Securities”under the NED Share Plan.Class Fully paid Ordinary SharesNumber acquired 8,032Number disposed N/A----- End of picture text -----
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Value/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuation | $40,000 cash equivalent using the volume weightedaverage price of Ordinary Shares over the five businessdays immediately following the Healius Limited AnnualGeneral Meeting on 21 October 2021, being $4.98. |
|---|---|
| No. of securities held afterchange | 16,064 Ordinary Shares*Gordon Davis55,759 Ordinary SharesGR & G DavisSuperannuation Fund*Shares are subject to a holding lock as “RestrictedSecurities” under the NED Share Plan. |
| Nature of changeExample: on-market trade, off-market trade,exercise of options, issue of securities under | Vesting of remaining 50% of NED Share Rights issuedin respect of FY 2022 into Ordinary Shares (restricted) |
| dividend reinvestment plan, participation in buy- | under the NED Share Plan. |
| back |
Part 2 – Change of director’s interests in contracts Not applicable
Part 3 –[+] Closed period
| art 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contractsdetailed above traded during a+closed period whereprior written clearance was required? | Not applicable |
| If so, was prior written clearance provided to allow thetrade to proceed during this period? | Not applicable |
| If prior written clearance was provided, on what datewas this provided? | Not applicable |
Authorised by the Company Secretary.
Charles Tilley Company Secretary Date: 02 September 2022
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011